Skin & hair

Treating a Field of Precancers, Option by Option

Save

When precancers cover a whole sun-damaged area, treating the field beats chasing individual spots. This compares the main options — 5-fluorouracil, imiquimod, photodynamic therapy, and gentler creams — by how they work, how sore they make the skin, and how long each takes. It also covers why the field keeps producing new spots and what monitoring still matters.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Continue in Claude

Open a chat with this article’s link already in the message, and keep asking questions there. Claude reads the article and its sources; nothing about you is included.

Continue in Claude →

The button opens the Claude desktop app and fills in the message for you to review before sending. No desktop app, or reading on a phone? Copy the prompt and paste it into any AI.

Field treatment versus freezing one spot

Freezing — cryotherapy — treats one visible actinic keratosis at a time with a few seconds of liquid nitrogen. Field treatment covers a whole patch of sun-damaged skin, including the early changes between the bumps you can already feel. Because years of sun exposure damage a broad area, new precancers keep surfacing there, a concept called field cancerization. Field therapy aims at that entire zone; cryotherapy is lesion-directed 1.

The practical question — one spot or the whole field — usually comes down to how many actinic keratoses there are and how densely they cluster. A single rough spot on an otherwise clear cheek is a candidate for freezing. A scalp or forehead studded with them, where you can feel more roughness than you can count, is where a field approach earns its keep, because it treats the visible lesions and the subclinical ones in the same course.

Actinic keratoses are often easier to feel than to see: a gritty, sandpaper-like roughness on sun-exposed skin, sometimes with a reddish or brownish scale that returns after it is scratched off. They collect on the areas that catch the most sun over a lifetime — the scalp of a balding head, the forehead, ears, cheeks, lower lip, forearms, and the backs of the hands. A clinician usually recognizes them by that texture and distribution, and reserves a biopsy for a spot that looks or feels different from the rest 1.

Field cancerization means a whole area of chronically sun-damaged skin carries genetic changes, so precancers arise across it rather than at one isolated point.

Cryotherapy: treating the spots you can feel

Cryotherapy is the most common way to treat individual actinic keratoses. A brief spray or dab of liquid nitrogen freezes the lesion; over the following week or two it blisters or crusts and sheds. It is fast, done in a single visit, and asks nothing of you at home, which makes it a natural choice for a handful of discrete spots 1.

The trade-off is coverage. Cryotherapy only treats what the clinician can see and freeze, leaving the surrounding sun-damaged field untouched — so on skin with widespread damage, new lesions keep appearing between treated spots. Its side effects are usually local and short-lived: pain during freezing, a blister or crust, and sometimes a pale mark where pigment does not fully return, which is more noticeable on darker skin 1. For someone with just a few lesions, none of that outweighs the speed and simplicity.

Cryotherapy also leaves a kind of record of what was treated, since each frozen spot heals as a discrete mark. But it says nothing about the skin in between, and it becomes impractical when there are dozens of lesions to freeze in one sitting — the time and the cumulative soreness both add up. That practical ceiling is often what moves the conversation from freezing toward a field approach 1.

5-fluorouracil: the field workhorse

5-fluorouracil — usually called 5-FU — is a cream applied to a whole sun-damaged area over a course of weeks. It is a chemotherapy agent that preferentially attacks rapidly dividing precancerous cells, so it inflames the abnormal spots while largely sparing normal skin. That selectivity is why treated skin gets red, crusted, and sore before it heals, and why the reaction tends to reveal precancers that were not visible before 1. It is among the best-studied field therapies.

The experience is the main thing to plan around. During and just after the course, the treated field can look alarming — bright red, weepy, crusted — which is expected rather than a sign something has gone wrong. It settles over a few weeks once the cream is stopped, leaving smoother skin. Because the visible reaction is hard to hide, many people time a 5-FU course around work and social commitments. What a 5-fluorouracil course actually feels like week by week is involved enough that it is worth reviewing in detail before starting.

Imiquimod: recruiting the immune system

Imiquimod is a cream that clears precancers by a different route than 5-FU. Rather than directly killing cells, it prompts the local immune system to recognize and attack the abnormal ones. It is applied to the field over several weeks and, like 5-FU, produces redness, crusting, and sometimes flu-like feelings while the immune response runs its course 1.

Because the reaction is immune-driven, its intensity varies more from person to person, and clinicians sometimes favor it for the face and scalp where a field response is wanted. The visible inflammation is again part of how it works, not a complication, and it fades after treatment ends. As with any field cream, the benefit depends on completing the course through the uncomfortable middle rather than stopping the moment the skin flares.

How well imiquimod is tolerated tends to track how vigorous the immune response is, so a strong reaction and a strong result often go together. Because the schedule is spread across weeks rather than applied daily for the whole stretch, some people find it fits around life more easily than a continuous course, while others find the on-again, off-again rhythm harder to keep to 1.

Photodynamic therapy: light-activated field treatment

Photodynamic therapy — PDT — is an in-office field treatment that compresses weeks of home cream into a clinic visit. A light-sensitizing solution is applied to the area and left to soak into the precancerous cells; it is then activated with a specific wavelength of light, which destroys them. It treats a broad field in one or two sessions rather than a multi-week regimen 1.

The trade-off is a concentrated version of the same inflammation. The light exposure itself can sting or burn, and the treated skin is red, swollen, and peeling for several days afterward, with strict sun avoidance in the window right after treatment. For people who would rather not manage a cream for weeks — or who struggle with adherence — this light-activated treatment for precancers moves the discomfort into a shorter, supervised span. What photodynamic therapy is like on the day, from the incubation wait to the light, is worth knowing before booking it.

Diclofenac and gentler options

Not every field treatment causes an intense reaction. Topical diclofenac, an anti-inflammatory gel, is applied over a longer stretch of weeks and is far gentler on the skin than 5-FU or imiquimod. The trade-off is that it generally clears fewer lesions and asks for more patience 1.

Gentler regimens have a real place. They suit people who cannot afford weeks of visible peeling — because of their work, their skin tone concerns, or simply their tolerance — and those who want a lower-key option for a milder field. The general rule across these creams is a see-saw: the treatments that produce the fiercest inflammation tend to clear the most, and the gentlest tend to clear the least. Choosing among them is less about finding the single best drug and more about matching that see-saw to what a person can realistically complete.

Cost, insurance coverage, and what a pharmacy actually stocks steer the choice more than people expect, since the field agents differ widely in price and availability. And the gentler route is not only about comfort: for someone with many mild lesions who is likely to need repeated rounds over the years, a treatment they will actually agree to repeat can clear more over time than a fierce one they undergo once and then refuse 1.

How to choose between them

The choice between field treatments is a trade-off between how thoroughly they clear the field and how much reaction you are willing to live through. 5-FU and imiquimod clear more but cause weeks of visible redness and crusting; photodynamic therapy compresses that into a clinic visit plus a few sore days; diclofenac is the gentlest but the least complete 1. There is rarely one right answer — the same person might choose differently for a scalp in winter than for a face before a wedding.

A few factors tend to tip the decision:

  • Site. The scalp, face, forehead, and backs of the hands each tolerate and heal differently, and some sites are easier to keep out of the sun during recovery.
  • Downtime. How many days of visible peeling fit around work and life.
  • Adherence. A home cream only works if it is used through the uncomfortable middle; an in-office session removes that variable.
  • Extent. A dense, widespread field argues for a treatment that covers everything at once.

It also helps to think in terms of a plan rather than a single event. Many people combine approaches over time — freezing a stubborn spot that survived a field course, or alternating field treatments across years as new lesions accumulate. The aim is durable control of a field that will keep trying to produce precancers, not a one-time cure, and the treatments are tools chosen for each round rather than rivals settled once 1.

The field treatments trade tolerability against completeness — the harder-to-tolerate options generally clear more, so the best choice is the effective one a person can actually finish.

What treatment doesn't finish: sun protection and monitoring

Clearing the field today does not stop new precancers tomorrow, because the underlying sun damage remains. Ongoing photoprotection is part of the plan: regular daily sunscreen use has been shown to reduce the incidence of melanoma in adults 2, and it slows the accumulation of new damage on skin that is already prone to it. Treated areas also tend to recur over time, which is why the same sun-damaged field is re-checked at intervals rather than considered finished after one course. Why precancers return to sun-damaged skin is really the story of that permanent underlying damage.

Monitoring matters for a harder reason. A field of actinic keratoses can hide a squamous cell carcinoma, and no one can tell the two apart by look or feel alone — not from a photo and not from a description. A spot that is thickening into a lump, becoming tender, bleeding, growing, or failing to clear with field treatment needs to be examined in person and, if there is any doubt, biopsied. The field treatments here are for precancers; they are not a treatment for a skin cancer that has already formed, and only a biopsy settles which is which. Because dermatologists are concentrated in metropolitan areas, being seen can take longer in rural regions, which is worth planning around when something changes 3.

Common questions

Spot treatment, usually cryotherapy, freezes individual visible lesions one at a time. Field treatment applies a cream or light-based therapy across a whole sun-damaged area to reach both the visible precancers and the early changes between them. Spot treatment suits a few discrete lesions; field treatment suits skin with widespread damage where new spots keep appearing.

5-FU targets rapidly dividing precancerous cells, so it inflames exactly the abnormal spots — including ones that were not visible — while mostly sparing normal skin. The redness, crusting, and soreness are the expected sign that it is working, not a complication. The reaction builds over the course and settles within a few weeks after the cream is stopped.

It depends on the treatment. Creams such as 5-fluorouracil and imiquimod produce redness and crusting over their multi-week course, then settle over a few weeks after stopping. Photodynamic therapy concentrates the reaction into several sore, peeling days after the session. Gentler options like diclofenac cause less visible reaction but work more slowly.

New actinic keratoses can appear in the same area over time, because the underlying sun damage that produced them remains. That is why treated fields are re-checked at intervals and why ongoing sun protection is part of the plan. Recurrence is not a sign the treatment failed — it reflects skin that stays prone to forming precancers.

Actinic keratoses are precancers, not cancer, but a proportion can progress to squamous cell carcinoma, and there is no reliable way to tell by sight which will. That uncertainty is exactly why they are treated and monitored rather than ignored. A lesion that thickens, bleeds, hurts, or resists treatment should be examined in person and biopsied if there is doubt.

There is no single best field treatment. The stronger options — 5-fluorouracil, imiquimod, and photodynamic therapy — clear more precancers but cause more visible reaction, while gentler creams cause less and clear less. The right choice matches the site, how much downtime is workable, and which regimen a person can realistically complete, and it is decided with a clinician.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When a rough spot needs a closer look

  • A spot that grows quickly, becomes a firm lump or open sore, bleeds, or hurts — features that can indicate a squamous cell carcinoma rather than a simple precancer, and that a photo or description cannot rule out.
  • An actinic keratosis that does not clear after a full course of field treatment, or that keeps returning in the same place.
  • A rapidly enlarging or tender lesion on the lip or ear, sites where skin cancers tend to behave more aggressively.

This article compares how fields of actinic keratoses are generally treated and cannot assess any individual lesion. No description or photograph can distinguish a precancer from a skin cancer; any changing, non-healing, or worrying spot should be evaluated in person by a clinician.

References

  1. 1.American Family Physician (2007). Treatment Options for Actinic Keratoses. American Family Physician. linkLesion-directed cryotherapy versus field therapies for actinic keratosis; how topical 5-fluorouracil, imiquimod, diclofenac, and photodynamic therapy work, their courses, and their adverse effects (pain, blistering, redness, crusting, hypopigmentation).
  2. 2.Green AC, Williams GM, Logan V, Strutton GM (2011). Reduced Melanoma After Regular Sunscreen Use: Randomized Trial Follow-Up. Journal of Clinical Oncology. PMID 21135266Regular daily sunscreen use reduces the incidence of melanoma in adults, supporting ongoing photoprotection as part of managing chronically sun-damaged skin.
  3. 3.Feng H, Berk-Krauss J, Feng PW, Stein JA (2018). Comparison of Dermatologist Density Between Urban and Rural Counties in the United States. JAMA Dermatology. PMID 28296988Dermatologists are concentrated in metropolitan areas, so access to in-person evaluation and clinic-based treatments can take longer for people in rural regions.

3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy